February 27, 2025 How the House’s Budget Plan Sets the Stage for a Fiscal Showdown
Tesla: Capturing Opportunity in a Contrarian Market
Microsoft: Resilient Amid Sell-Off, 'Buy' Stance Reaffirmed
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
Clovis Oncology (CLVS) stock forecast for 2026
Updated: March 2, 2025 (10:36)
Sector: HealthcareThe share price of Clovis Oncology, Inc. (CLVS) now
50/200 Day Moving Average: $ / $
This figure corresponds to the Average Price over the previous 50/200 days. For Clovis Oncology stocks, the 50-day moving average is the support level today.
For Clovis Oncology stocks, the 200-day moving average is the support level today.
Are you interested in Clovis Oncology, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Clovis Oncology stock price in 2026. How much will one Clovis Oncology share be worth in 2026? Is it worth taking profit / loss on CLVS stock now or waiting? What are analysts' forecasts for Clovis Oncology stock?
We forecast Clovis Oncology stock performance using neural networks based on historical data on CLVS stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Clovis Oncology, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Clovis Oncology analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).
Historical and forecast chart of Clovis Oncology, Inc. stock
The chart below shows the historical price of Clovis Oncology stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CLVS stock price can be found in the table below.
Clovis Oncology, Inc., a biopharmaceutical company, specializes in the acquisition, development and commercialization of anti-cancer agents in the United States, the European Union and internationally. The company offers Rubraca (rucaparib), an oral small molecule poly-ADP-ribose polymerase inhibitor for the treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Clovis Oncology (CLVS) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.07 | 0.06 | 0.08 | 20.20 % |
| Feb | 0.06 | 0.06 | 0.08 | 22.37 % |
| Mar | 0.06 | 0.05 | 0.08 | 29.80 % |
| Apr | 0.07 | 0.06 | 0.08 | 14.80 % |
| May | 0.08 | 0.07 | 0.10 | 27.24 % |
| Jun | 0.09 | 0.08 | 0.10 | 21.53 % |
| Jul | 0.08 | 0.07 | 0.10 | 28.46 % |
| Aug | 0.07 | 0.06 | 0.08 | 24.00 % |
| Sep | 0.09 | 0.08 | 0.10 | 20.38 % |
| Oct | 0.10 | 0.08 | 0.12 | 30.49 % |
| Nov | 0.09 | 0.07 | 0.10 | 33.09 % |
| Dec | 0.07 | 0.07 | 0.08 | 14.65 % |
Clovis Oncology information and performance
N/A
Market capitalization of the Clovis Oncology, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CLVS shares in the company outstanding by the market price of one share.
EBITDA of Clovis Oncology is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Clovis Oncology price target for 2026 by month
Target values for the price of one Clovis Oncology share for Jan 2026.
In Jan, the Positive dynamics for Clovis Oncology, Inc. shares will prevail with possible monthly volatility of 20.197% volatility is expected.
Pessimistic target level: 0.06
Optimistic target level: 0.08
Target values for the price of one Clovis Oncology share for Feb 2026.
In Feb, the Negative dynamics for Clovis Oncology, Inc. shares will prevail with possible monthly volatility of 22.370% volatility is expected.
Pessimistic target level: 0.06
Optimistic target level: 0.08
Target values for the price of one Clovis Oncology share for Mar 2026.
In Mar, the Negative dynamics for Clovis Oncology, Inc. shares will prevail with possible monthly volatility of 29.802% volatility is expected.
Pessimistic target level: 0.05
Optimistic target level: 0.08
Target values for the price of one Clovis Oncology share for Apr 2026.
In Apr, the Positive dynamics for Clovis Oncology, Inc. shares will prevail with possible monthly volatility of 14.800% volatility is expected.
Pessimistic target level: 0.06
Optimistic target level: 0.08
Target values for the price of one Clovis Oncology share for May 2026.
In May, the Positive dynamics for Clovis Oncology, Inc. shares will prevail with possible monthly volatility of 27.242% volatility is expected.
Pessimistic target level: 0.07
Optimistic target level: 0.10
Target values for the price of one Clovis Oncology share for Jun 2026.
In Jun, the Positive dynamics for Clovis Oncology, Inc. shares will prevail with possible monthly volatility of 21.527% volatility is expected.
Pessimistic target level: 0.08
Optimistic target level: 0.10
Target values for the price of one Clovis Oncology share for Jul 2026.
In Jul, the Negative dynamics for Clovis Oncology, Inc. shares will prevail with possible monthly volatility of 28.461% volatility is expected.
Pessimistic target level: 0.07
Optimistic target level: 0.10
Target values for the price of one Clovis Oncology share for Aug 2026.
In Aug, the Negative dynamics for Clovis Oncology, Inc. shares will prevail with possible monthly volatility of 24.001% volatility is expected.
Pessimistic target level: 0.06
Optimistic target level: 0.08
Target values for the price of one Clovis Oncology share for Sep 2026.
In Sep, the Positive dynamics for Clovis Oncology, Inc. shares will prevail with possible monthly volatility of 20.381% volatility is expected.
Pessimistic target level: 0.08
Optimistic target level: 0.10
Target values for the price of one Clovis Oncology share for Oct 2026.
In Oct, the Positive dynamics for Clovis Oncology, Inc. shares will prevail with possible monthly volatility of 30.489% volatility is expected.
Pessimistic target level: 0.08
Optimistic target level: 0.12
Target values for the price of one Clovis Oncology share for Nov 2026.
In Nov, the Negative dynamics for Clovis Oncology, Inc. shares will prevail with possible monthly volatility of 33.086% volatility is expected.
Pessimistic target level: 0.07
Optimistic target level: 0.10
Target values for the price of one Clovis Oncology share for Dec 2026.
In Dec, the Negative dynamics for Clovis Oncology, Inc. shares will prevail with possible monthly volatility of 14.648% volatility is expected.
Pessimistic target level: 0.07
Optimistic target level: 0.08
Related stocks from Healthcare sector
